A Tennessee woman has filed a lawsuit against GlaxoSmithKline (GSK) alleging that the anti-nausea medication Zofran caused her daughter to be born with catastrophic heart defects that led to her death at the age of just 11 weeks.
Free Zofran Lawsuit Evaluation: If your child was harmed by Zofran side effects, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer and our lawyers can help.
Update: Tennessee Mother Blames Zofran for Daughter’s Heart Defects
February 9, 2016 – Another Tennessee woman who allegedly took Zofran during pregnancy and gave birth to a child with heart defects has filed a lawsuit against GSK. According to the complaint, plaintiff started taking Zofran in August 2000 for morning sickness during her first trimester, and subsequently gave birth to a girl with severe heart defects including pulmonary valve stenosis and atrial septal defect. The woman claims that neither she nor anyone else in her family have a history of heart defects, and that in an earlier pregnancy which did not involve the use of Zofran she gave birth to a healthy baby girl.
What’s the Problem?
According to the lawsuit, plaintiff took Zofran for morning sickness throughout her first trimester of pregnancy (a time when the fetus’ heart tissue is initially developing), and was even administered the drug intravenously at a hospital on ‘several occasions.’ Her daughter, ‘N.R.’, was born on June 23, 2014, and subsequently diagnosed with the following heart defects:
- Heterotaxy Syndrome (Isomerism) – Heart on the right side of her body, rather than on left as normal.
- Atrioventricular Septal Defect (AVSD) – Defect in which there are holes in the chambers of the heart, and the valves that control the flow of blood between the chambers may not be formed correctly.
- Aortic Insufficiency (AI) – Leaking of the aortic valve of the heart that causes blood to flow in the reverse direction during ventricular diastole, from the aorta into the left ventricle.
As a result of these problems, N.R. was transferred immediately after her birth to a neonatal intensive care unit (NICU) and placed on life support machines. Sadly, the baby died at 11 weeks old, just before a heart transplant surgery was scheduled.
Like other plaintiffs in Zofran lawsuits, the Tennessee mother claims her daughter’s exposure to the drug was the result of a fraudulent marketing campaign run by GSK. She sites a 2012 lawsuit filed by the U.S. Justice Department which charged the drugmaker with illegally promoting Zofran and other medications to OB / GYNs.
GSK’s marketing campaign portrayed Zofran as a ‘safe and effective’ treatment for morning sickness, even though the drug had never been tested or approved for this purpose, according to the lawsuit. The complaint was filed September 4 in U.S. District Court for the State of Tennessee, Middle District, Nashville, under case #3:15-cv-00958. Since the initial filing, this case was transferred to Boston, MA. to be consolidated in the Zofran multidistrict litigation.
Do I Have a Zofran Birth Defect Lawsuit?
The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Zofran Lawsuits. We are handling individual litigation nationwide and currently accepting new birth defects cases in all 50 states.
Free Confidential Case Evaluation: Again, if your baby was born with a heart defect, cleft palate, kidney damage or other birth defects after the mother took Zofran during pregnancy, you should contact our law firm immediately. You may be entitled to a settlement by filing a class action suit and we can help.